Cubilin has recently been shown to function as an endocytic receptor for high density lipoproteins (HDL). The lack of apparent transmembrane and cytoplasmic domains in cubilin raises questions as to the means by which it can mediate endocytosis. Since cubilin has been reported to bind the endocytic receptor megalin, we explored the possibility that megalin acts in conjunction with cubilin to mediate HDL endocytosis. While megalin did not bind to HDL, delipidated HDL, or apoA-I, it was found to copurify with cubilin isolated by HDL-Sepharose affinity chromatography. Cubilin and megalin exhibited coincident patterns of mRNA expression in mouse tissues including the kidney, ileum, thymus, placenta, and yolk sac endoderm. The expression of both receptors in yolk sac endoderm-like cells was inducible by retinoic acid treatment but not by conditions of sterol depletion. Suppression of megalin activity or expression by treatment with either megalin antibodies or megalin antisense oligodeoxynucleotides resulted in inhibition of cubilin-mediated endocytosis of HDL. Furthermore, megalin antisense oligodeoxynucleotide treatment resulted in reduced cell surface expression of cubilin. These data demonstrate that megalin acts together with cubilin to mediate HDL endocytosis and further suggest that megalin may play a role in the intracellular trafficking of cubilin.
Cubilin has recently been shown to function as an endocytic receptor for high density lipoproteins (HDL). The lack of apparent transmembrane and cytoplasmic domains in cubilin raises questions as to the means by which it can mediate endocytosis. Since cubilin has been reported to bind the endocytic receptor megalin, we explored the possibility that megalin acts in conjunction with cubilin to mediate HDL endocytosis. While megalin did not bind to HDL, delipidated HDL, or apoA-I, it was found to copurify with cubilin isolated by HDL-Sepharose affinity chromatography. Cubilin and megalin exhibited coincident patterns of mRNA expression in mouse tissues including the kidney, ileum, thymus, placenta, and yolk sac endoderm. The expression of both receptors in yolk sac endoderm-like cells was inducible by retinoic acid treatment but not by conditions of sterol depletion. Suppression of megalin activity or expression by treatment with either megalin antibodies or megalin antisense oligodeoxynucleotides resulted in inhibition of cubilin-mediated endocytosis of HDL. Furthermore, megalin antisense oligodeoxynucleotide treatment resulted in reduced cell surface expression of cubilin. These data demonstrate that megalin acts together with cubilin to mediate HDL endocytosis and further suggest that megalin may play a role in the intracellular trafficking of cubilin.
Cubilin is a recently identified receptor that mediates binding and endocytosis of intrinsic factor-vitamin B 12 complex (1), immunoglobulin light chains (2) , and high density lipoproteins (HDL) 1 (3, 4) . The primary sequence of the ϳ460-kDa cubilin polypeptide lacks a discernible membrane-spanning element (1, 5) . However, a sequence located in the amino-terminal region having amphipathic helical characteristics has been implicated in plasma membrane anchoring/association (6) . It is not clear how such a "peripheral" association allows interaction of cubilin with cytosolic components of the endocytic machinery. A plausible hypothesis is that an integral membrane protein(s) functions in concert with cubilin to facilitate the endocytic activities. The principal candidate for such an accessory protein is megalin (also known as gp330 and LRP-2), a member of the low density lipoprotein receptor family. Megalin binds cubilin and colocalizes with it in apical endocytic invaginations and endosomes of renal proximal tubule cells and yolk sac epithelial cells (1) . In the present study, the role of megalin in cubilin-mediated endocytosis of HDL is examined.
EXPERIMENTAL PROCEDURES
Proteins-Human apolipoprotein A-I (apoA-I) was obtained from Dr. Bryan Brewer (Molecular Disease Branch, NHLBI, National Institutes of Health, Bethesda, MD). Megalin was purified from porcine kidney as described previously (7) .
Lipoproteins-Human DiI-HDL was purchased from Biomedical Technologies. Human HDL (density ϭ 1.063-1.21 g/ml) and LDL were provided by Dr. Bryan Brewer. Delipidated HDL (apoHDL) was prepared as described (8) . DiI-HDL and HDL were depleted of apoE-HDL and other heparin-binding particles according to Oram (9) , dialyzed against 150 mM NaCl, 50 mM Tris, pH 7.4 (Tris-buffered saline) containing 0.3 mM EDTA and filter-sterilized. Lipoprotein concentration was determined by BCA protein assay (Pierce).
Antibodies-Rabbit polyclonal (rb239 and rb6286) and mouse monoclonal megalin (6C53C3) antibodies have been described previously (10, 11) . Rabbit anti-megalin IgG was purified by protein-G-Sepharose and then affinity-selected by chromatography on megalin-Sepharose (12) . Rabbit anti-cubilin serum was provided by Dr. Pierre Verroust (Hospital Tenon, Paris, France), and IgG was purified by protein G-Sepharose chromatography. A rabbit polyclonal antiserum was raised against an amino-terminal segment of rat cubilin (residues 21-473) expressed in bacteria as a fusion protein with glutathione S-transferase using the pGEX6P vector (Amersham Pharmacia Biotech). The resulting antiserum was preabsorbed on glutathione S-transferase-Sepharose, and IgG was purified using protein G-Sepharose chromatography. Rabbit anti-megalin (rb6286) and rabbit anti-cubilin amino-terminal segment IgGs were labeled with fluorescein isothiocyanate (FITC) and tetramethylrhodamine, respectively, according to the instructions of the manufacturer (Pierce). Rabbit anti-LDLR (711) was obtained from Dr. Joachim Herz (University of Texas Southwestern Medical Center, Dallas, TX). Horseradish peroxidase-conjugated anti-IgGs were obtained from Amersham Pharmacia Biotech.
Cells-Murine sarcoma virus-transformed Brown Norway rat yolk sac cells (BN cells) were provided by Dr. Pierre Verroust (Hospital Tenon, Paris, France). Mouse embryonal teratocarcinoma F9 cells (ATCC CRL1720) were differentiated by treatment with retinoic acid and dibutyryl cyclic AMP for 6 days as described previously (13) .
HDL-Sepharose Affinity Chromatography-HDL-Sepharose affinity chromatography was performed as described previously (4) , with the exception that detergent extracts of BN cells were used.
Enzyme-linked Immunosorbent Assays-Enzyme-linked immunosorbent assays were performed as described previously (11) . Megalin (150 nM in Tris-buffered saline, 0.05% Tween 20) was incubated with microtiter wells coated with LDL, HDL, apoHDL, apoA-I, or ovalbumin (3 g/ml). Bound receptor was detected using the monoclonal megalin antibody 6C53C3, sheep anti-mouse IgG-horse radish peroxidase, and the chromogenic substrate o-phenylenediamine (Sigma).
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‡ These two authors contributed equally to this work. § Recipient of a fellowship from the AHA. 1 The abbreviations used are: HDL, high density lipoprotein(s); LDL, low density lipoprotein(s); LDLR, LDL receptor; FITC, fluorescein isothiocyanate; PCR, polymerase chain reaction; DiI, 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate; RAP, receptor-associated protein; ODN, oligodeoxynucleotide; LRP, LDLR-related protein; uPA, urokinase-type plasminogen activator; uPAR, uPA receptor; PAI-1, plasminogen activator inhibitor-1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. mouse tissues and from BN cells using RNA Stat-60 (Tel-Test, Inc.) according to the manufacturer's specifications. Reverse transcription of total mRNA using random hexamer oligodeoxynucleotide primers and cDNA synthesis were performed as described previously (14) . For the design of mouse cubilin amplification primers, a GenBank TM search was used to identify an orthologous mouse cubilin cDNA (clone ID C0026H06) having 87.6% similarity to rat cubilin cDNA and encoding a polypeptide with 87.3% identity to the rat cubilin carboxyl terminus. For the design of mouse megalin primers, a 686-base pair cDNA sequence (GenBank TM accession no. AF197160) was assembled from 14 overlapping mouse expressed sequence tags (GenBank TM accession numbers C80829, AI047614, AU043137, AA574617, AU043459, AA109222, AA082958, AA109769, AU045327, AU045353, AU045179, AI436683, AA617362, and AI025985). This 686-base pair cDNA is 92.6% identical to rat megalin cDNA and encodes a polypeptide 93.4% similar to the rat megalin carboxyl terminus. The PCR primer sequences used in this study are shown in Table I . Primer pairs and cDNA templates were tested over a range of amplification cycles to determine an optimal cycle number for exponential phase of production. Reactions were performed with Taq polymerase (0.2 units/l) (Qiagen), 1ϫ PCR buffer (Qiagen), 1.6 mM total dNTP, 0.2 M primers, and 2.5 mM MgCl 2 . Annealing temperatures and cycles of amplification for each primer pair are as follows: mouse cubilin, 53°C, 28 cycles; mouse megalin, 54°C, 28 cycles; mouse GAPDH, 53°C, 22 cycles; rat cubilin, 52°C, 20 cycles; rat megalin, 61°C, 23 cycles; rat LDLR, 52°C, 27 cycles.
Confocal Microscopic Analysis of Cubilin and Megalin in Cultured Yolk
Sac Endoderm-like Cells-Cells were plated into wells of plastic chamber slides (Nalge Nunc) (4 ϫ 10 4 cells/cm 2 ) and incubated for 18 h at 37°C in complete medium (minimal essential medium containing 10% fetal bovine serum, 100 units/ml penicillin, 100 g/ml streptomycin). The cells were washed once with serum-free medium (minimal essential medium, ITS (5 g/ml insulin, 5 g/ml transferrin, 5 ng/ml sodium selenite; Roche Molecular Biochemicals), penicillin/streptomycin) and incubated for 4 h in serum-free medium at 37°C. Fluorescently labeled IgGs (FITC-anti-megalin and rhodamine-anti-cubilin aminoterminal segment (residues 21-473) were added (final concentration, 50 g/ml each) in the presence or absence of HDL (final concentration, 200 g/ml) or RAP (final concentration, 2 M) and incubated for 1 h at 37°C. The cells were washed with Dulbecco's phosphate-buffered saline, fixed in 3% formaldehyde in Dulbecco's phosphate-buffered saline for 20 min, and analyzed by confocal microscopy.
Analysis of the Effect of Retinoic Acid and Dibutyryl Cyclic AMP on Receptor Expression-Mouse embryonal teratocarcinoma F9 cells were seeded onto 0.1% gelatin-coated plates at 1 ϫ 10 2 cells/cm 2 and cultured for 6 days in Dulbecco's modified Eagle's medium (Mediatech), 10% iron-fortified bovine calf serum (Hyclone), 100 units/ml penicillin, and 100 g/ml streptomycin in the presence or absence of 0.1 M retinoic acid (Sigma) or 0.2 M dibutyryl cyclic AMP (Sigma). The medium was then removed, and the cells were extracted with detergent buffer (1% Triton X-100, 0.5% Tween 20, 0.5 M NaCl, 50 mM Hepes, pH 7.5, containing a protease inhibitor mixture (EDTA-free; Roche Molecular Biochemicals)). Protein concentrations in the extracts were determined by the BCA protein assay (Pierce). Equal amounts (20 g) of protein were run on Novex gels (4 -12% polyacrylamide gradient) and transferred to polyvinylidene difluoride membranes. Membrane-bound proteins were detected with receptor-specific antibodies, horseradish peroxidase-conjugated anti-IgG, and ECL-plus (Amersham Pharmacia Biotech).
Analysis of the Effect of Sterol on Receptor Expression-BN cells were cultured at 1-1.5 ϫ 10 5 cells/cm 2 in complete medium for 6 h. The medium was replaced with serum-free medium (minimal essential medium, ITS; Roche Molecular Biochemicals), penicillin/streptomycin) containing either 1) mevalonic acid lactone (50 M) (Sigma) and sterols (25-hydroxycholesterol (1 g/ml) and cholesterol (10 g/ml)); 2) mevalonic acid lactone (50 M) and compactin/mevastatin (50 M) (Calbiochem); 3) sterols; or 4) compactin/mevastatin (50 M). The cells were cultured for 72 h at 37°C, 5% CO 2 (15) . The medium was then removed, and the cells were extracted with detergent and centrifuged at 100,000 ϫ g. Equal amounts (5 g) of protein from each extract were analyzed by immunoblotting as described above. (Table II) were synthesized with phosphorothioate ester linkages (the first two and the last three linkages) and with phosphodiester linkages elsewhere. Immunoblot analysis was performed on cell extracts as described above. Cell surface receptor levels were evaluated by flow cytometry after releasing the cells from culture plates with 2 mM EDTA in Dulbecco's phosphate-buffered saline and then washing the cells with serum-free medium, 0.1% sodium azide, 2% normal goat serum and incubating the cells with receptor antibodies and FITCconjugated goat anti-IgG. For flow cytometry analysis, the cells were washed with serum-free medium and then incubated with serum-free medium containing DiI-HDL (2 g/ml) and oligodeoxynucleotide for 1.5 h at 37°C, 5% CO 2 . The cells were then washed, stripped of cell surface-associated DiI-HDL by treatment with 0.5 mg/ml trypsin, 50 g/ml proteinase K, 0.53 mM EDTA in Dulbecco's phosphate-buffered saline and subjected to flow cytometry (FACStar Plus, Becton Dickinson).
Antisense Oligodeoxynucleotide Treatment of Cells and Analysis of Receptor Activity and Expression-BN

RESULTS
Megalin Copurifies with Cubilin-Recently, we have demonstrated that cubilin can be isolated from cultured yolk sac endoderm-like cells using HDL-Sepharose affinity chromatography (4). To determine whether megalin co-purifies with cubilin, immunoblot analysis was performed on cubilin-containing fractions eluted from HDL-Sepharose. As shown in Fig. 1 , the peak cubilin-containing fraction also contained megalin, detectable with a monoclonal antibody. In enzyme-linked immunosorbent assays, megalin did not bind to HDL, delipidated HDL (apoHDL), or to purified apoA-I, the major apolipoprotein constituent of HDL (Fig. 2) . This supports the concept that the presence of megalin in the HDL-Sepharose column eluates was due to an association with cubilin rather than a direct interaction with the affinity matrix. These results are consistent with the previously reported finding that cubilin and megalin interact with high affinity (1) .
Cubilin and Megalin Expression Analysis-The expression of cubilin and megalin mRNAs in mouse tissues was evaluated by reverse transcription-PCR. As shown in Fig. 3 , the overall patterns of cubilin and megalin transcript expression are overlapping. Cubilin and megalin transcripts were co-expressed in the kidney, thymus, ileum, placenta, and yolk sac. The only exception was in the lung, where megalin mRNA expression was detectable but cubilin mRNA was not.
The expression of both cubilin and megalin has been shown to be stimulated in mouse F9 cells treated with a combination of retinoic acid and dibutyryl cyclic AMP (4, 13) . To determine the effect of these agents separately on the expression of cubilin and megalin, F9 cells were cultured in the presence of each agent, and the level of receptor expression was evaluated immunologically. As shown in Fig. 4 , retinoic acid treatment stimulated expression of both cubilin and megalin, whereas dibutyryl cyclic AMP treatment alone had no effect on expression of either receptor (Fig. 4) .
The fact that both cubilin and megalin are involved with lipoprotein catabolism also prompted us to determine whether the expression of either receptor was sterol-responsive, similar to the LDLR. Neither sterol-depleted conditions nor treatment with the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, compactin, increased the accumulation of cubilin or megalin mRNA or protein as was observed for the LDLR (Fig. 5) .
The similarity in response of the two receptors to a regulatory stimulus (Fig. 4) , together with the similarity in tissue expression (Fig. 3) , supports the hypothesis that they may have a functional relationship. Further support for such a relationship comes from confocal microscopic studies of the subcellular distribution of cubilin and megalin in cultured yolk sac endoderm-like cells (Fig. 6 ). Cubilin and megalin displayed a coincident pattern of subcellular distribution consistent with an endocytic vesicle localization (Fig. 6, upper row) . Treatment of the cells with RAP, an antagonist of ligand-binding to megalin, leads to a reduction in the number of punctate foci stained by cubilin antibody (Fig. 6) . In contrast, RAP treatment caused a reduction in the intensity of the vesicular staining pattern of megalin but not a major reduction in the number of punctate foci per cell (Fig. 6 ). These findings suggest that RAP prevents cubilin from becoming efficiently internalized into endocytic vesicles while not affecting the internalization of megalin. The observed reduction in intensity of megalin staining caused by RAP could be the result of masking of epitopes or destruction of epitopes through alteration of megalin conformation. Administration of HDL abolished the vesicular staining patterns for both receptors. Since HDL does not bind to megalin (Fig. 6) , these latter findings suggest that binding of HDL to cubilin sterically or allosterically prevents antibody binding to megalin, a possibility made more plausible if the two receptors existed in a complex.
Megalin Antibodies Inhibit Cubilin-mediated Uptake of HDL-To determine whether megalin plays a role in endocytosis of cubilin ligands, function-blocking megalin antibodies were tested for their ability to perturb HDL uptake by cultured endoderm-like cells. Megalin antibodies were found to effectively inhibit the uptake of DiI-HDL (Fig. 7) . The inhibitory effect of the megalin antibodies was apparent as a Ͼ40% reduction of the number of cells in the population that internalized DiI-HDL (Fig. 7A ) as well as a Ͼ30% reduction in the amount of DiI-HDL that the cells internalized (Fig. 7B) . Cubi- lin antibodies had similar effects on the uptake of DiI-HDL.
Megalin Antisense Oligodeoxynucleotides Inhibit HDL Uptake-An antisense oligodeoxynucleotide (ODN) approach was also employed to abrogate megalin expression and evaluate the consequence on cubilin-mediated HDL uptake. Cultured endoderm-like cells were treated with a series of ODNs complementary to megalin mRNA. As shown in Fig. 8 , treatment of the cells with one of the antisense ODNs (A2) greatly inhibited uptake of DiI-HDL in comparison with the sense sequence of this ODN (S2) or other megalin sense and antisense ODNs (Fig. 8A) . The specificity of antisense ODN A2 treatment on megalin protein production was confirmed by immunoblot analysis of detergent extracts of the treated cells. Treatment of cells for 20 h with A2 reduced the level of megalin in cell extracts by Ͼ50% (Fig. 8B) . Analysis of the level of megalin expressed on the surface of the A2-treated cells was performed by flow cytometry. As shown in Fig. 8C , cells treated with the megalin antisense ODN A2 for 20 h had cell surface levels of megalin ϳ50% that of cells treated with the megalin sense ODN S2. Immunoblot analysis of the conditioned culture medium from cells treated with A2 and S2 revealed no overt difference in cubilin levels (not shown).
Analysis of the effects of antisense ODN A2 treatment on cubilin and LDLR protein levels in total cell extracts was also performed. As shown in Fig. 8B , A2 treatment slightly increased (ϳ5%) the levels of cubilin and LDLR in total cell extracts as compared with cells treated with the sense ODN S2. Flow cytometry analysis of cubilin expression on the surface of the A2-treated cells showed ϳ20% reduction in levels of cubilin as compared with the control (Fig. 8C) . By contrast, there was no difference in cell surface levels of LDLR in cells treated with A2 and S2. 
DISCUSSION
The findings reported in this study add new dimensions to the function of megalin. First, the findings indicate that megalin can act in concert with another cell surface protein to mediate ligand endocytosis. Similar cooperative relationships have been reported for a close relative of megalin, low density lipoprotein receptor-related protein (LRP) (16) . LRP cooperates with cell surface proteoglycans to mediate endocytosis of several ligands including thrombospondin-1 (17, 18) and hepatic lipase (19) . Furthermore, LRP and the urokinase receptor (uPAR) cooperate in the process of endocytosis of urokinasetype plasminogen activator-plasminogen activator inhibitor-1 complexes (uPA⅐PAI-I) (20) . Similar to cubilin, uPAR lacks a membrane-spanning element, but it is glycosylphosphatidylinositol-anchored to the plasma membrane. Since megalin can mediate uptake of uPA⅐PAI-I (21), it is plausible that megalin can also function in concert with uPAR to mediate uPA⅐PAI-I uptake. Such a process would, however, be distinct from megalin-mediated uptake of HDL in that uPA⅐PAI-I binds to megalin (21) but HDL and its apolipoprotein component apoA-I do not (Fig. 2) . Therefore, in the process of HDL/apoA-I uptake, a transfer of HDL/apoA-I from cubilin to megalin does not seem feasible. Alternatively, megalin may mediate endocytosis of a complex of cubilin and HDL/apoA-I.
An additional dimension to the functionality of megalin is highlighted by the observation that megalin antisense oligodeoxynucleotide treatment leads to reduced cell surface expression of cubilin. This result suggests that megalin may play a role in the biosynthetic trafficking of cubilin. Impaired cubilin trafficking to apical brush border membranes of ilieum and renal proximal tubule epithelial cells has been described in a canine model for the human autosomal recessive ImerslundGrasbeck syndrome (22, 23) . The molecular basis for the canine disorder, which involves defective intestinal absorption of intrinsic factor-vitamin B 12 complex, was speculated to involve mutations within the cubilin gene as was the case for human Imerslund-Grasbeck syndrome (24) . However, a recent study has demonstrated that the canine disorder is not caused by a defect in the cubilin gene (25) . In light of our findings, it is possible that a mutation within the gene for megalin or its biosynthetic trafficking chaperone protein, RAP, accounts for the impaired cell surface expression of cubilin observed in the affected dogs.
